Purification and characterization of insulin-mimetic inositol phosphoglycan-like molecules from grass pea (Lathyrus sativus) seeds.
BACKGROUND
Signal transduction through the hydrolysis of glycosyl-phosphatidylinositol (GPI) leading to the release of the water-soluble inositol phosphoglycan (IPG) molecules has been demonstrated to be important for mediating some of the actions of insulin and insulin-like growth factor-I (IGF-I).


METHODS
In the present study, GPI from grass pea (Lathyrus sativus) seeds has been purified and partially characterized on the basis of its chromatographic properties and its compositional analysis.


RESULTS
The results indicate that it shows similarities to GPI previously isolated from other sources such as rat liver. IPG was generated from L. sativus seed GPI by hydrolysis with a GPI-specific phospholipase D (GPI-PLD). This IPG inhibited protein kinase A (PKA) in an in vitro assay, caused cell proliferation in explanted cochleovestibular ganglia (CVG), and decreased 8-Br-cAMP-induced phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression in cultured hepatoma cells.


CONCLUSIONS
Our data indicate that L. sativus seed IPG possess insulin-mimetic activities. This may explain why L. sativus seeds have been used in some traditional medicines to ameliorate diabetic symptoms.
Pañeda
C
C
Instituto de Investigaciones Biomédicas Alberto Sols (C.S.I.C.), Madrid, Spain.
Villar
A V
AV
Alonso
A
A
Goñi
F M
FM
Varela
F
F
Brodbeck
U
U
León
Y
Y
Varela-Nieto
I
I
Jones
D R
DR
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002642:Chick Embryo; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors; D005227:Fatty Acids / Q000032:analysis; D005724:Ganglia / Q000166:cytology / Q000187:drug effects; D015870:Gene Expression / Q000187:drug effects; D017261:Glycosylphosphatidylinositols / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D006868:Hydrolysis; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology*; D027807:Lathyrus / Q000737:chemistry*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000037:antagonists & inhibitors; D011134:Polysaccharides / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology*; D051381:Rats; D012639:Seeds / Q000737:chemistry
D005227:Fatty Acids; D017261:Glycosylphosphatidylinositols; D007295:Inositol Phosphates; D007328:Insulin; D011134:Polysaccharides; C028039:inositol phosphate glycan; D017868:Cyclic AMP-Dependent Protein Kinases; D010729:Phosphoenolpyruvate Carboxykinase (GTP)